Publications

CRIMALDDI Roadmap (Malaria Journal 2013)

A prioritized research agenda to expedite the discovery of new anti-malarial drugs. The Coordination, Rationalization, and Integration of anti-MALarial drug Discovery & Development Initiatives (CRIMALDDI) Consortium has been a three-year project funded by the EU Framework Seven Pr
Continue Reading →

The future of the Affordable Medicines Facility – malaria (AMFm) (December 2012)

At the end of 2012, Ian Boulton was asked to present his views on the results of the Affordable Medicines Facility – malaria (AMFm) at the 11th Assises Panafricaines de Lutte Contre le Paludisme (11th Pan-African National Malaria Control Programmes Meeting), sponsored and organi
Continue Reading →

Rapid Diagnostic Tests: the Private Sector (December 2012)

At the end of 2012, Ian Boulton was asked to present on malaria diagnosis in the private retail sector at the 11th Assises Panafricaines de Lutte Contre le Paludisme (11th Pan-African National Malaria Control Programmes Meeting), sponsored and organised Sanofi, under the title:- Mise
Continue Reading →

RBM AMFM Landscape Paper (May 2012)

The Affordable Medicines Facility – malaria (AMFm) was an initiative piloted in Africa. Its main objective was to increase access to Quality Assured Artemisinin-containing Combination Treatments (QAACTs) through a co-payment mechanism. The co-payment was intended to reduce the end-use
Continue Reading →

ALMA Consultation on African-based Pharmaceutical Manufacture (May 2011)

In May 2011, the African Leaders’ Malaria Alliance (ALMA), the Global Fund, the Medicines for Malaria Venture (MMV), and the Roll Back Malaria Partnership sponsored a Forum for Africa-based Pharmaceutical Manufacturers and Potential Investors in Nairobi. It aimed to bring togeth
Continue Reading →

CRIMALDDI Overview (Malaria Journal 2010)

A co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives. Despite increasing efforts and support for anti-malarial drug R&D, globally anti-malarial drug discovery and development remains largely uncoordinated and fragmen
Continue Reading →

RBM Accountability Framework (December 2009)

Following the Roll Back Malaria Partnership (RBM) Change Initiative in 2006 and the quadrennial External Evaluation in 2009, the RBM Board established a Task Force to develop an Accountability Framework to guide the work and responsibilities of all the RBM Partners.  TropMed Pharma Co
Continue Reading →

Global Health Diagnostics: Research, Development, & Regulation (December 2008)

In December 2008, Ian Boulton was asked to present on “A Private Sector Perspective” at an Academy of Medical Sciences Conference Global Health Diagnostics: Research, Development, & Regulation. Founded in 1998, the Academy of Medical Sciences is the independent body in
Continue Reading →

“Connecting the Chain” Forum (June 2006)

In 2006, the Dutch Ministry of Foreign Affairs, the European & Developing Countries Clinical Trials Partnership (EDCTP), and the Netherlands-African partnership for Capacity development and Clinical interventions Against Poverty-related diseases (NACCAP) organised a Stakeholder Fo
Continue Reading →